Frontiers in Molecular Neuroscience,
Journal Year:
2025,
Volume and Issue:
17
Published: Jan. 22, 2025
Parkinson’s
disease
(PD)
involves
the
disruption
of
brain
energy
homeostasis.
This
encompasses
broad-impact
factors
such
as
mitochondrial
dysfunction,
impaired
glycolysis,
and
other
metabolic
disturbances,
like
disruptions
in
pentose
phosphate
pathway
purine
metabolism.
Cortical
hubs,
which
are
highly
connected
regions
essential
for
coordinating
multiple
functions,
require
significant
due
to
their
dense
synaptic
activity
long-range
connections.
Deficits
ATP
production
PD
can
severely
impair
these
hubs.
The
imbalance
also
affects
subcortical
regions,
including
massive
axonal
arbors
striatum
substantia
nigra
pars
compacta
neurons,
high
demand.
decline
may
result
α
-synuclein
accumulation,
autophagy-lysosomal
system
impairment,
neuronal
network
breakdown
accelerated
neurodegeneration.
We
propose
an
“ATP
Supply–Demand
Mismatch
Model”
help
explain
pathogenesis
PD.
model
emphasizes
how
deficits
drive
pathological
protein
aggregation,
autophagy,
degeneration
key
networks,
contributing
both
motor
non-motor
symptoms.
Environmental Toxicology,
Journal Year:
2024,
Volume and Issue:
39(7), P. 4022 - 4034
Published: April 15, 2024
Abstract
Mitochondrial
dysfunction,
a
common
cellular
hallmark
in
both
familial
and
sporadic
forms
of
Parkinson's
disease
(PD),
is
assumed
to
play
significant
role
pathologic
development
progression
the
disease.
Teaghrelin,
unique
bioactive
compound
some
oolong
tea
varieties,
has
been
demonstrated
protect
SH‐SY5Y
cells
against
1‐methyl‐4‐phenylpyridinium
induced
neurotoxicity
by
binding
ghrelin
receptor
activate
AMPK/SIRT1/PGC‐1α
pathway.
In
this
study,
an
animal
model
was
established
using
neurotoxin,
1‐methyl‐4phenyl‐1,2,3,6‐tetrahydropyridine
(MPTP),
byproduct
prohibited
drug,
evaluate
oral
efficacy
teaghrelin
on
PD
monitoring
motor
dysfunction
mice
open
field,
pole,
bean
walking
tests.
The
results
showed
that
MPTP‐induced
significantly
attenuated
supplementation.
Tyrosine
hydroxylase
dopamine
transporter
protein
were
found
reduced
striatum
midbrain
MPTP‐treated
mice,
mitigated
Furthermore,
administration
enhanced
mitophagy
mitochondria
biogenesis,
which
maintained
cell
homeostasis
prevented
accumulation
αSyn
apoptosis‐related
proteins.
It
seemed
protected
dopaminergic
neurons
increasing
PINK1/Parkin‐mediated
AMPK/SIRT1/PGC‐1α‐mediated
highlighting
its
potential
therapeutic
maintaining
function
PD.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(1), P. 73 - 73
Published: Jan. 5, 2024
Parkinson’s
disease
(PD)
is
the
second
most
prevalent
neurodegenerative
movement
disorder
worldwide,
which
primarily
characterized
by
motor
impairments.
Even
though
multiple
hypotheses
have
been
proposed
over
decades
that
explain
pathogenesis
of
PD,
presently,
there
are
no
cures
or
promising
preventive
therapies
for
PD.
This
could
be
attributed
to
intricate
pathophysiology
PD
and
poorly
understood
molecular
mechanism.
To
address
these
challenges
comprehensively,
a
thorough
model
imperative
nuanced
understanding
PD’s
underlying
pathogenic
mechanisms.
review
offers
detailed
analysis
current
state
knowledge
regarding
mechanisms
with
particular
emphasis
on
roles
played
gene-based
factors
in
disease’s
development
progression.
study
includes
an
extensive
discussion
proteins
mutations
primary
genes
linked
including
α-synuclein,
GBA1,
LRRK2,
VPS35,
PINK1,
DJ-1,
Parkin.
Further,
this
explores
plausible
DAergic
neural
loss,
non-motor
non-dopaminergic
pathologies,
risk
associated
The
present
will
encourage
related
research
fields
understand
better
analyze
status
biochemical
might
contribute
design
efficacious
safe
treatment
strategies
future
endeavors.
Molecular Psychiatry,
Journal Year:
2024,
Volume and Issue:
29(2), P. 505 - 517
Published: Jan. 3, 2024
Mitochondrial
DNA
single
nucleotide
polymorphisms
(mtSNPs)
have
been
associated
with
a
reduced
risk
of
developing
Parkinson's
disease
(PD),
yet
the
underlying
mechanisms
remain
elusive.
In
this
study,
we
investigate
functional
role
PD-associated
mtSNP
that
impacts
mitochondrial-derived
peptide
(MDP)
Small
Humanin-like
Peptide
2
(SHLP2).
We
identify
m.2158
T
>
C,
PD
risk,
within
small
open
reading
frame
encoding
SHLP2.
This
results
in
an
alternative
form
SHLP2
(lysine
4
replaced
arginine;
K4R).
Using
targeted
mass
spectrometry,
detect
specific
tryptic
fragments
neuronal
cells
and
demonstrate
its
binding
to
mitochondrial
complex
1.
Notably,
observe
K4R
variant,
exhibits
increased
stability
compared
WT
Additionally,
both
show
enhanced
protection
against
dysfunction
vitro
experiments
confer
PD-inducing
toxin,
1
inhibitor,
mouse
model.
study
sheds
light
on
consequences
C
provides
insights
into
potential
by
which
may
reduce
PD.
Huntington's
disease
(HD)
is
a
devastating
neurodegenerative
that
manifested
by
gradual
loss
of
physical,
cognitive,
and
mental
abilities.
As
the
advances,
age
has
major
impact
on
pathogenic
signature
mutant
huntingtin
(mHTT)
protein
aggregation.
This
review
aims
to
explore
intricate
relationship
between
aging,
mHTT
toxicity,
cellular
senescence
in
HD.
Scientific
data
interplay
mHTT,
HD
were
collected
from
several
academic
databases,
including
PubMed,
Google
Scholar,
Google,
ScienceDirect.
The
search
terms
employed
"AGING,"
"HUNTINGTON'S
DISEASE,"
"MUTANT
HUNTINGTIN,"
"CELLULAR
SENESCENCE."
Additionally,
gather
information
molecular
mechanisms
potential
therapeutic
targets,
was
extended
include
relevant
such
as
"DNA
DAMAGE,"
"OXIDATIVE
STRESS,"
"AUTOPHAGY."
According
research,
aging
leads
worsening
pathophysiology
through
some
processes.
result
accumulation,
promoted,
which
causes
DNA
damage,
oxidative
stress,
decreased
autophagy,
increased
inflammatory
responses.
Pro-inflammatory
cytokines
other
substances
are
released
senescent
cells,
may
worsen
neuronal
damage
course
disease.
It
been
shown
treatments
directed
at
these
pathways
reduce
symptoms
enhance
longevity
experimental
animals,
pointing
new
possibility
treating
condition.
Through
their
amplification
harmful
effects
play
crucial
roles
development
Comprehending
interplays
creates
novel
opportunities
for
measures
targeted
alleviating
enhancing
patients'
quality
life.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: May 10, 2023
Parkinson’s
disease
(PD),
the
second
most
common
neurodegenerative
worldwide,
often
occurs
in
middle-aged
and
elderly
individuals.
The
pathogenesis
of
PD
is
complex
includes
mitochondrial
dysfunction,
oxidative
stress.
Recently,
natural
products
with
multiple
structures
their
bioactive
components
have
become
one
important
resources
for
small
molecule
drug
research
targeting
dysfunction.
Multiple
lines
studies
proven
that
display
ameliorative
benefits
treatment
by
regulating
Therefore,
a
comprehensive
search
recent
published
articles
between
2012
2022
PubMed,
Web
Science,
Elesvier,
Wliey
Springer
was
carried
out,
focusing
on
original
publications
related
to
against
restoring
This
paper
presented
mechanisms
various
kinds
PD-related
dysfunction
regulation
provided
evidence
are
promising
be
developed
as
drugs
therapeutics.
Journal of Proteome Research,
Journal Year:
2024,
Volume and Issue:
23(8), P. 3025 - 3040
Published: April 3, 2024
Despite
the
recent
and
increasing
knowledge
surrounding
COVID-19
infection,
underlying
mechanisms
of
persistence
symptoms
for
a
long
time
after
acute
infection
are
still
not
completely
understood.
Here,
multiplatform
mass
spectrometry-based
approach
was
used
metabolomic
lipidomic
profiling
human
plasma
samples
from
Long
COVID
patients
(n
=
40)
to
reveal
mitochondrial
dysfunction
when
compared
with
individuals
fully
recovered
mild
40).
Untargeted
analysis
using
CE-ESI(+/−)-TOF-MS
GC-Q-MS
performed.
Additionally,
LC-ESI(+/−)-QTOF-MS
based
on
an
in-house
library
revealed
447
lipid
species
identified
high
confidence
annotation
level.
The
integration
complementary
analytical
platforms
has
allowed
comprehensive
metabolic
characterization
alterations
in
disease
that
found
46
relevant
metabolites
which
discriminate
between
patients.
We
report
specific
altered
COVID,
mainly
related
decrease
amino
acid
metabolism
ceramide
levels
increase
tricarboxylic
(TCA)
cycle,
reinforcing
evidence
impaired
function.
most
shown
this
study
will
help
better
understand
insights
syndrome
by
providing
deeper
basis
pathology.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: June 11, 2024
Abstract
Impairment
of
the
central
nervous
system
(CNS)
poses
a
significant
health
risk
for
astronauts
during
long-duration
space
missions.
In
this
study,
we
employed
an
innovative
approach
by
integrating
single-cell
multiomics
(transcriptomics
and
chromatin
accessibility)
with
spatial
transcriptomics
to
elucidate
impact
spaceflight
on
mouse
brain
in
female
mice.
Our
comparative
analysis
between
ground
control
spaceflight-exposed
animals
revealed
alterations
essential
processes
including
neurogenesis,
synaptogenesis
synaptic
transmission,
particularly
affecting
cortex,
hippocampus,
striatum
neuroendocrine
structures.
Additionally,
observed
astrocyte
activation
signs
immune
dysfunction.
At
pathway
level,
some
spaceflight-induced
changes
exhibit
similarities
neurodegenerative
disorders,
marked
oxidative
stress
protein
misfolding.
integrated
serves
as
stepping
stone
towards
understanding
CNS
impairments
at
level
individual
regions
cell
types,
provides
basis
comparison
future
studies.
For
broader
scientific
impact,
all
datasets
from
study
are
available
through
interactive
data
portal,
well
National
Aeronautics
Space
Administration
(NASA)
Open
Science
Data
Repository
(OSDR).